<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">DEXPANTHENOL (PANTOTHENIC ACID)</span><br/>(dex-pan'the-nole)<br/><span class="topboxtradename">Dexol, </span><span class="topboxtradename">Ilopan, </span><span class="topboxtradename">Panthoderm<br/></span><b>Classifications:</b> <span class="classification">autonomic nervous system agent</span>; <span class="classification">cholinergic, direct acting</span><br/><b>Prototype: </b>Bethanechol<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>250 mg/mL injection</p>
<h1><a name="action">Actions</a></h1>
<p>Analog of the coenzyme vitamin pantothenic acid, to which it is readily converted. A member of the B-complex group and precursor
         of coenzyme A, which is essential to normal epithelial function and biosynthesis of fatty acids, amino acids, and acetylcholine.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Increases GI peristalsis and intestinal tone by stimulating acetylcholine. Topical application reportedly relieves itching
         and may aid healing of skin lesions by stimulating epithelialization and granulation.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Prevention or treatment of postoperative abdominal distention, intestinal atony, and paralytic ileus. Topically to relieve
         itching and to promote healing in minor skin lesions.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hemophilia; ileus due to mechanical obstruction. Safe use during pregnancy (category C), lactation, or in children is not
         established.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Hypokalemia.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Postoperative Abdominal Distension, Intestinal Atony, Paralytic Ileus</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IM</span> 250500 mg, repeat in 2 h, then repeat q412h prn <span class="rdroute">IV</span> 500 mg by slow IV infusion<br/><span class="rdage">Child:</span> <span class="rdroute">IM</span> 1112.5 mg/kg, repeat in 2 h, then repeat q412h prn<br/><br/><span class="indicationtitle">Itching</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Topical</span> Apply to affected area 12 times/d<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Topical</span><br/><ul>
<li>Do not administer within 1 h of succinylcholine.</li>
</ul><span class="adminroutetype">Intramuscular</span><br/><ul>
<li>Give deep IM into a large muscle.</li>
</ul>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><p><span class="routemethod">PREPARE:</span> <span class="methodtype"> IV infusion:</span>  Dilute in at least 500 mL of D5W or RL.  
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype"> IV infusion:</span> Infuse slowly over 36 h.  
               </p>
</td>
</tr>
</table>
<ul>
<li>Store at 15°30° C (59°86° F); protect from freezing and excessive heat.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">All:</span> Generally well tolerated. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span>  Prolongs muscle relaxation effects of <b>succinylcholine.</b>
<h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from IM site. <span class="typehead">Distribution:</span> Highest concentration in liver, adrenals, heart, and kidneys; small amount distributed into breast milk. <span class="typehead">Metabolism:</span> Rapidly converted to pantothenic acid, the active moiety. <span class="typehead">Elimination:</span> 70% excreted in urine, 30% in feces. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for therapeutic effectiveness: May not see results in patients with hypokalemia until potassium imbalance is corrected.</li>
<li>Observe for and report bleeding tendency. Dexpanthenol may prolong bleeding time in some patients.</li>
<li>Report immediately any evidence of a hypersensitivity reaction (see Appendix F); drug should be discontinued.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report abdominal cramping or diarrhea to physician.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>